Development of a Tumor-Selective Approach to Treat Metastatic Cancer

• Karen S. Aboody ,

  *To whom correspondence should be addressed. E-mail: kaboody@coh.org (KSA); mary.danks@stjude.org (MKD)

  Affiliation Divisions of Hematology/Hematopoietic Cell Transplantation and Neurosciences, and Department of Professional Education, City of Hope National Medical Center, Duarte, California, United States of America

  ⨯
• Rebecca A. Bush,

  Affiliation Department of Molecular Pharmacology, St. Jude Children's Research Hospital, Memphis, Tennessee, United States of America

  ⨯
• Elizabeth Garcia,

  Affiliation Divisions of Hematology/Hematopoietic Cell Transplantation and Neurosciences, and Department of Professional Education, City of Hope National Medical Center, Duarte, California, United States of America

  ⨯
• Marianne Z. Metz,

  Affiliation Divisions of Hematology/Hematopoietic Cell Transplantation and Neurosciences, and Department of Professional Education, City of Hope National Medical Center, Duarte, California, United States of America

  ⨯
• Joseph Najbauer,

  Affiliation Divisions of Hematology/Hematopoietic Cell Transplantation and Neurosciences, and Department of Professional Education, City of Hope National Medical Center, Duarte, California, United States of America

  ⨯
• Kristine A. Justus,

  Affiliation Divisions of Hematology/Hematopoietic Cell Transplantation and Neurosciences, and Department of Professional Education, City of Hope National Medical Center, Duarte, California, United States of America

  ⨯
• Doris A. Phelps,

  Affiliation Department of Molecular Pharmacology, St. Jude Children's Research Hospital, Memphis, Tennessee, United States of America

  ⨯
• Joanna S. Remack,

  Affiliation Department of Molecular Pharmacology, St. Jude Children's Research Hospital, Memphis, Tennessee, United States of America

  ⨯
• Karina Jin Yoon,

  Affiliation Department of Molecular Pharmacology, St. Jude Children's Research Hospital, Memphis, Tennessee, United States of America

  ⨯
• Shanna Gillespie,

  Affiliation Divisions of Hematology/Hematopoietic Cell Transplantation and Neurosciences, and Department of Professional Education, City of Hope National Medical Center, Duarte, California, United States of America

  ⨯
• Seung U. Kim,

  Affiliations Department of Medicine, University of British Columbia Hospital, Vancouver, British Columbia, Canada, Ajou University School of Medicine, Suwon, South Korea

  ⨯
• Carlotta A. Glackin,

  Affiliation Divisions of Hematology/Hematopoietic Cell Transplantation and Neurosciences, and Department of Professional Education, City of Hope National Medical Center, Duarte, California, United States of America

  ⨯
• Philip M. Potter,

  Affiliation Department of Molecular Pharmacology, St. Jude Children's Research Hospital, Memphis, Tennessee, United States of America

  ⨯
• Mary K. Danks

  *To whom correspondence should be addressed. E-mail: kaboody@coh.org (KSA); mary.danks@stjude.org (MKD)

  Affiliation Department of Molecular Pharmacology, St. Jude Children's Research Hospital, Memphis, Tennessee, United States of America

  ⨯